Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
31-60 of 372
31-60 of 372
Filter
Beau Whitney
Chief Economist at Whitney Economics
agriculture, bank, cannabidiol, cannabinoid, cannabis, cash crop, commodity broker, commodity market, cotton, direct marketing, hemp, inventory, loan, market (economics), marketplace, option (finance), price, retail, soybean, speculation, supply and demand, tax, tetrahydrocannabinol, unemployment, wheat
Chase Hubbard
Senior Analyst at The Jacobsen
agriculture, bank, cannabidiol, cannabinoid, cannabis, cash crop, commodity broker, commodity market, cotton, direct marketing, hemp, inventory, loan, market (economics), marketplace, option (finance), price, retail, soybean, speculation, supply and demand, tax, tetrahydrocannabinol, unemployment, wheat
Bill Richmond
Chief at U.S. Domestic Hemp Production Program
background check, biodiversity, biotechnology, cannabidiol, cannabinoid, colorado state university, controlled substance, cornell university, economics, employment, farmer, food safety, hemp, joke, law of the united states, mathematics, negligence, oregon state university, plant breeding, regulatory compliance, rulemaking, sampling (statistics), tetrahydrocannabinolic acid, uncertainty, united states congress
Andrew Corrieri
Consultant and founder at Pharmaconsulta Lt
addiction, black market, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical trial, cold medicine, consciousness, dose (biochemistry), drug, drug overdose, education, federal government of the united states, good manufacturing practice, heroin, hiv/aids in the united states, inspection, joe biden, laboratory, logistics, medical cannabis, medication, morphine, narcotic, opiate, opioid, opioid use disorder, opium, palliative care, pharmaceutical industry, pharmacovigilance, pharmacy, physician, postmarketing surveillance, prescription drug, prohibition of drugs, psychedelic drug, quality management system, regulation of therapeutic goods, regulatory affairs, substance dependence, target market, warehouse
Matthew Lawson
Co-Founder at The Canna Consultants
adverse effect, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, controlled substance, criminalization, dose (biochemistry), drug, drug policy, european union, evidence-based medicine, explanation, food, jurisdiction, law, medical cannabis, medication, medicine, mining, multidisciplinary association for psychedelic studies, narcotic, netherlands, nevis, novel food, opioid, opium, over-the-counter drug, pharmacy, physician, prescription drug, prohibition of drugs, psilocybin, regulatory compliance, smuggling, switzerland, tetrahydrocannabinol, traditional chinese medicine, u.s. state, war on drugs
Stephen Oliver
Co-Founder at The Canna Consultants
addiction, adverse effect, black market, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical trial, cold medicine, consciousness, controlled substance, criminalization, dose (biochemistry), drug, drug overdose, drug policy, european union, explanation, federal government of the united states, food, hiv/aids in the united states, joe biden, jurisdiction, law, medical cannabis, medication, mining, narcotic, netherlands, novel food, opioid, opioid use disorder, pharmaceutical industry, prescription drug, prohibition of drugs, psychedelic drug, regulation of therapeutic goods, smuggling, substance dependence, switzerland, tetrahydrocannabinol, u.s. state, war on drugs
Vasko Dinev
CEO at Talisker CRO
advertising, agriculture, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis (drug), cannabis cultivation, clinical trial, covid-19 pandemic, dose (biochemistry), drug, evidence-based medicine, feeling, food, good clinical practice, hash oil, hemp, human, jurisdiction, justice, medical cannabis, medication, medicine, mind, multidisciplinary association for psychedelic studies, nevis, opioid, opium, over-the-counter drug, pharmacy, physician, potato, prescription drug, psilocybin, psychoactive drug, regulatory compliance, tablet (pharmacy), tetrahydrocannabinol, traditional chinese medicine, understanding
Henri Sant-Cassia
Co-Founding Partner at The Conscious Fund
addiction, antidepressant, black market, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical trial, cold medicine, competition, consciousness, dose (biochemistry), drug, drug overdose, epilepsy, epileptic seizure, esketamine, federal government of the united states, hiv/aids in the united states, joe biden, johnson & johnson, major depressive disorder, medical cannabis, medication, mental health, opioid, opioid use disorder, pain management, pharmaceutical industry, pharmacy, post-traumatic stress disorder, prescription drug, prohibition of drugs, psychedelic drug, psychiatry, psychosis, regulation of therapeutic goods, substance dependence, synthetic cannabinoids, telehealth, thailand, treatment-resistant depression
Albert Tió
President at Federation of Self-regulated Cannabis Associations of Catalonia (Fedcac) at FEDCAC
addiction, awareness, black market, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), celebrity, change.org, clinical trial, cold medicine, consciousness, constitution of spain, dose (biochemistry), drug, drug overdose, european union, evidence-based medicine, federal government of the united states, federation, hiv/aids in the united states, joe biden, jurisdiction, law, market (economics), medical cannabis, medication, medicine, mental disorder, mental health, multidisciplinary association for psychedelic studies, national labor relations board, nevis, news, nonprofit organization, opioid, opioid use disorder, opium, over-the-counter drug, pharmaceutical industry, pharmacy, physician, prescription drug, profit (economics), prohibition of drugs, psilocybin, psychedelic drug, regulation of therapeutic goods, regulatory compliance, science, smoking, spain, substance dependence, supreme court of the united kingdom, supreme court of the united states, tetrahydrocannabinol, tobacco, traditional chinese medicine, wealth
Farid Ghehioueche
Head of advocacy at FAAAT - For Alternative Approaches to Addiction - Think & do tank
canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), clinical trial, debate, dose (biochemistry), drug, drug policy, evidence, evidence-based medicine, international law, jurisdiction, medical cannabis, medication, medicine, mind, morphine, multidisciplinary association for psychedelic studies, narcotic, nevis, opioid, opium, over-the-counter drug, pain, pharmacy, physician, policy, prescription drug, psilocybin, psychotherapy, regulatory compliance, science, substance abuse, substance dependence, tetrahydrocannabinol, traditional chinese medicine, united nations office on drugs and crime, world health organization
Marcus Ramkissoon
Cannabis Expert Advisor at Caribbean Cannabis Institute
adherence (medicine), brazil, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis (drug), central america, clinical trial, dose (biochemistry), drug, ethics, european union, evidence-based medicine, food, health, insurance, intellectual property, international narcotics control board, jamaica, jurisdiction, law, medical cannabis, medical school, medication, medicine, multidisciplinary association for psychedelic studies, nevis, opioid, opium, over-the-counter drug, pharmacy, physician, prescription drug, property, psilocybin, regulation, regulatory compliance, safety, south america, tetrahydrocannabinol, traditional chinese medicine, treaty, youtube
Robert W.E. Laurie
Advisory Board Member (MAPS Canada) at Multidisciplinary Association for Psychedelic Studies (MAPS)
2019, addiction, alcoholism, alternative, attorney general, bank, biohacking, biotech, blinded experiment, business, cambridge house, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis (drug), cannabis act, capital, clinical trial, cognitive behavioral therapy, company, compass pathways, consciousness, controlled substance, coronavirus disease 2019, criminalization, dennis mckena, denver, dose (biochemistry), downtown eastside, drug, drug education, drug policy reform, education, entrepreneur, event, evidence-based medicine, extraordinary future, finance, food and drug administration, gabor mate, gabor maté (physician), hallucinogen, harm reduction, health care, holistic, ibogaine, johns hopkins university, jr rahn, jurisdiction, lars wilde, legality of cannabis, lysergic acid diethylamide, major depressive disorder, market, matthew johnson, mdma, medical cannabis, medication, medicine, mental health, micro dosing, mind, mindmed, money, monopoly, motivation, motivational interviewing, multidisciplinary association for psychedelic studies, mushrooms, nevis, opioid, opium, over-the-counter drug, panel, pardon, pharmacy, physician, placebo, prescription drug, prosecutor, psilocybin, psilocybin mushroom, psychedelics, psychotherapy, public, regulation of therapeutic goods, regulatory compliance, science, silicon valley, social control, spiritual, stock, substance abuse, tech, tetrahydrocannabinol, the doors of perception, therapy, tim ferriss, traditional chinese medicine, treatment, treatment-resistant depression, united states attorney, varenicline, war on drugs, xf
Dustin Robinson
Founding Partner at Mr. Cannabis Law
advertising, angel investor, bank, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), caregiver, clinical trial, commerce clause, dividend, dividend tax, doctor–patient relationship, dose (biochemistry), dronabinol, drug, economics, employment, evidence-based medicine, expense, flow-through entity, food and drug administration, franchising, innovation, interest, internal revenue service, investment, joe biden, jurisdiction, legality of cannabis, limited liability company, limited liability partnership, loan, major depressive disorder, market (economics), mdma, medical cannabis, medication, medicine, mergers and acquisitions, mergers, and acquisitions, multidisciplinary association for psychedelic studies, nevis, opioid, opium, over-the-counter drug, ownership, pain management, partnership, pharmacy, physician, prescription drug, price, psilocybin, psychedelic drug, rate of return, regulatory compliance, seed money, social stigma, supply chain, tax, tax rate, tetrahydrocannabinol, traditional chinese medicine, unemployment, valuation (finance)
Cheryl Shuman
Chief Executive Officer at Beverly Hills Cannabis Club
addiction, bill maher, black market, brand, cannabidiol, cannabinoid, cannabis, cannabis (drug), cash crop, cbs, clinical trial, cold medicine, coming out, consciousness, dose (biochemistry), drug, drug overdose, federal government of the united states, fox business, hiv/aids in the united states, joe biden, joe rogan, medical cannabis, medication, milk, nbc, netflix, nursing, opioid, opioid use disorder, personal branding, pharmaceutical industry, prescription drug, product placement, prohibition of drugs, psychedelic drug, regulation of therapeutic goods, ricki lake, sanjay gupta, social media, substance dependence, television, the view (talk show), tommy chong, toy, vlog, wheat, whoopi goldberg, willie nelson
Bob Hoban
Global Cannabis Influencer at Hoban Law Group
biomass, bioplastic, canadian federalism, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis sativa, cereal, clinical trial, clothing, dietary supplement, dose (biochemistry), drug, economy, ethanol, evidence-based medicine, food, food security, hemp, jurisdiction, medical cannabis, medication, medicine, multidisciplinary association for psychedelic studies, nevis, nutraceutical, oil, opioid, opium, over-the-counter drug, pharmacy, physician, prescription drug, psilocybin, regulatory compliance, retail, sustainability, tetrahydrocannabinol, textile, thailand, traditional chinese medicine, wheat
Deanna Callahan
COO at Gateway Proven Strategies
brand, business, cannabidiol, cannabinoid, cannabis, cannabis industry, capital (economics), colgate (toothpaste), colorado, corporation, cotton, denver, economy, education, food, hemp, infrastructure, innovation, investment, medication, pfizer, startup company, supply chain, texas, united states
Andrew Agius
Medical Director at MD MSc PGC ​
adverse effect, antidepressant, anxiety, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabis (drug), cannabis edible, cannabis sativa, cannabis strain, chronic fatigue syndrome, chronic pain, cognitive behavioral therapy, dose (biochemistry), drug, drug enforcement administration, endocannabinoid system, epilepsy, family medicine, fibromyalgia, gateway drug effect, major depressive disorder, medical cannabis, medical prescription, medication, medicine, national health service, nursing, pain, paresthesia, personalized medicine, pharmacy, physical therapy, physician, post-traumatic stress disorder, prescription drug, psychiatrist, psychological trauma, psychosis, pulmonary fibrosis, residency (medicine), self-medication, symptom, tetrahydrocannabinol, topical medication
Michael Patterson
CEO at US Cannabis Pharmaceutical Research and Development
apple inc., brand, cannabidiol, cannabinoid, cannabis, clothing, cryptocurrency, customs, drug enforcement administration, export, good manufacturing practice, health care, hemp, joint venture, medical cannabis, money, novel food, nursing, pain, pharmacy, renewable resource, science, tetrahydrocannabinol, u.s. securities and exchange commission, ubs
Uma Dhanabalan
Founder/CEO at LLC/Uplifting Health & Wellness
addiction, analgesic, bronchodilator, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), cannabis edible, chemical synapse, chronic fatigue syndrome, cigarette, doctor of medicine, dopamine, drug, drug enforcement administration, drug overdose, endocannabinoid system, epilepsy, family medicine, fibromyalgia, gateway drug effect, health care, homeostasis, major depressive disorder, medical cannabis, medical prescription, medication, medicine, migraine, national health service, nursing, omega-6 fatty acid, opioid use disorder, personalized medicine, pharmacy, physician, prescription drug, pulmonary fibrosis, residency (medicine), self-medication, serotonin, social stigma, symptom, synapse, tetrahydrocannabinol, traumatic brain injury
Tracy Ryan
Founder at CannaKids & SavingSophie.org
alternative medicine, antibiotic, autism, autoimmune disease, brain tumor, bruise, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis and parenting, cannabis edible, cannamom, caregiver, chemotherapy, childhood cancer, civility, clinical trial, consciousness, coronavirus disease 2019, democratic party (united states), dose (biochemistry), edema, epilepsy, eric swalwell, experience, glioma, immune system, immunology, inflammation, influenza, knowledge, medical cannabis, medicine, mind, mindfulness, mom, mom shame, moms, mouse, natural killer cell, parenting, parenting and cannabis, psychology, republican party (united states), rodent, sleep, stereotype, tetrahydrocannabinol, truth, united states congress, virus, women, women in cannabis, womxn, womxn in cannabis
Priscilla Agoncillo
Co-Founder at Original Breeders League
agriculture, anti-inflammatory, antidepressant, anxiolytic, autism, belief, brand, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, cannabis strain, clinical trial, consciousness, cotton, crispr, crispr gene editing, democratic party (united states), disease, dispensary, dna, dna sequencing, dominance (genetics), dose (biochemistry), dravet syndrome, dronabinol, education, emergency medical technician, endocannabinoid system, entourage effect, epilepsy, ethnobotany, food and drug administration, free market, gene, gene mapping, genetic engineering, genetically modified organism, genetics, genome, gerrymandering, good manufacturing practice, hair loss, hashish, health, health care, hemp, human genome, landrace, major depressive disorder, management of depression, mdma, mechanism of action, medical cannabis, medication, medicine, mental disorder, mental health, micropropagation, mood stabilizer, neuroplasticity, neurotransmitter, neutron, organism, paramedic, pediatrics, pharmaceutical industry, pharmacology, pharmacy, plant tissue culture, post-traumatic stress disorder, psilocybin, psilocybin mushroom, psychedelic drug, psychiatry, psychoactive drug, psychology, schizophrenia, science, selective serotonin reuptake inhibitor, sense, sequencing, serotonin, substance dependence, swing state, syndrome, tetrahydrocannabinol, tony montana, treatment-resistant depression, whole genome sequencing
Joseph Rosado
Physician and Medical Director at International Medical Consultants and Cannabidiol Life
adalimumab, alzheimer's disease, analgesic, anti-inflammatory, anticoagulant, antipsychotic, appetite, arthritis, autoimmune disease, benzodiazepine, bioavailability, bipolar disorder, bleeding, brand, bronchodilator, budtender, cancer, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabinol, cannabis, cannabis (drug), cannabis edible, cannabis indica, cannabis industry, cannabis sativa, cannabis strain, cerebellum, certificate of analysis, chemical synapse, chronic condition, chronic fatigue syndrome, depression (mood), diabetes, dispensary, dopamine, dose (biochemistry), dravet syndrome, drug, drug enforcement administration, drug overdose, edema, education, effects of cannabis, emergency department, emergency medical technician, endocannabinoid system, epilepsy, family medicine, fibromyalgia, food and drug administration, free market, gateway drug effect, good manufacturing practice, gpr55, hair loss, heartburn, hiv, homeostasis, hydroxychloroquine, hypertension, indication (medicine), insomnia, irritable bowel syndrome, lupus, medical cannabis, medical prescription, medical school, medication, medicine, mental disorder, mental health, methotrexate, morphine, national health service, nervous system, norepinephrine, nursing, omega-6 fatty acid, opiate, opioid, oxycodone, oxycodone/paracetamol, pain management, paracetamol, paramedic, parkinson's disease, pediatrics, peripheral neuropathy, personalized medicine, pharmaceutical industry, pharmacology, pharmacy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, prescription drug, psilocybin mushroom, psychological trauma, pulmonary fibrosis, randomized controlled trial, residency (medicine), rhabdomyosarcoma, rheumatoid arthritis, schizophrenia, self-medication, serotonin, spasticities, sports medicine, sympathetic nervous system, symptom, synapse, syndrome, tetrahydrocannabinol, tetrahydrocannabinolic acid, tetrahydrocannabivarin, therapeutic index, tony montana, topical medication, transgenerational trauma, vagus nerve, vagus nerve stimulation, vaporizer (inhalation device), warfarin
Jacquie Cohen Roth
Founder & CEO at CannabizMD
adjuvant therapy, adverse effect, autism, cannabidiol, cannabinoid, cannabis (drug), cannabis edible, caregiver, chemotherapy-induced nausea and vomiting, chronic fatigue syndrome, doctor of osteopathic medicine, dose (biochemistry), drug, drug enforcement administration, epilepsy, expanded access, family medicine, fibromyalgia, gateway drug effect, health, health care, medical cannabis, medical prescription, medication, medicine, mental health, national health service, neurology, nursing, osteopathic medicine in the united states, personalized medicine, pharmacology, pharmacy, physician, prescription drug, psychosis, pulmonary fibrosis, residency (medicine), self-medication, symptom, tetrahydrocannabinol, therapy
Mauro F Cardoso Lins
Medical Director at Clinica Escola Do Autista translates as School Clinic for Autism
adherence (medicine), ageing, antipsychotic, anxiety, attention deficit hyperactivity disorder, autism, autism spectrum, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), clinical psychology, diarrhea, disease, dog, electroencephalography, emergency department, endocannabinoid system, epilepsy, epileptic seizure, fish oil, food and drug administration, hash oil, health care, health claim, hemp, medical cannabis, medication, medicine, mental disorder, miracle, mitochondrion, neurology, pain, pharmaceutical industry, pharmacist, physician, placebo, psychotherapy, regulatory compliance, science, spectrum disorder, tetrahydrocannabinol
Sandra Carrillo
Professor at Medical Cannabis Research & Education
agriculture, anticonvulsant, benzodiazepine, cancer, cannabidiol, cannabinoid, cannabinoid receptor, cannabinoid receptor type 1, cannabinoid receptor type 2, chemotherapy, clinical trial, computer security, dose (biochemistry), drug, endocannabinoid system, evidence-based medicine, fibromyalgia, food and drug administration, forecasting, headache, medical cannabis, medication, opiate, opioid, pain, pain management, peripheral neuropathy, physician, placebo, placebo-controlled study, post-traumatic stress disorder, psychiatrist, psychology, psychotherapy, public company, question, science, spasticity, substance abuse, synapse, technology, tetrahydrocannabinol, water
Srinivasa Reddy
Scientific Director and COO at Leaf Cross Biomedical
biochemistry, biopharmaceutical, cancer, cannabidiol, cannabinoid, cannabis, clinical trial, doctor of philosophy, domestication, ecology, engineering, environmental issues, evidence-based medicine, health, human, medication, medicine, metabolism, natural environment, pharmacy, question, radiation, science, terpene, tetrahydrocannabinol
Sung Seok Kang
Representative at Korea Medical Cannabis Organization
agriculture, asia, bluetooth, cancer, cannabidiol, cannabinoid, cannabis, cannabis (drug), cannabis in south korea, clinical trial, computer security, contract, coronavirus disease 2019, cosmetics, crime, dog, dose (biochemistry), drug, easter, food and drug administration, forecasting, irony, korea, medical cannabis, medical tourism, medication, north korea, opioid, pain, pain management, physician, post-traumatic stress disorder, psychiatrist, psychoactive drug, psychology, psychotherapy, public company, question, science, south korea, spamming, technology, tetrahydrocannabinol, united states, water, world war ii
Pratik Karki
Co-Venturer, Chairperson and CEO at ReEvolution JV
agriculture, cannabidiol, cannabinoid, cannabis, clinical trial, consciousness, cotton, crispr, crispr gene editing, disease, dna, dna sequencing, ethnobotany, gene mapping, genetically modified organism, genome, hashish, health, hemp, landrace, mental disorder, neutron, science, sequencing, tetrahydrocannabinol
Johan Mohamad
President at MHIRA
agriculture, cannabidiol, cannabinoid, cannabis, clinical trial, consciousness, cotton, crispr, crispr gene editing, disease, dna, dna sequencing, ethnobotany, gene mapping, genetically modified organism, genome, hashish, health, hemp, landrace, mental disorder, neutron, science, sequencing, tetrahydrocannabinol
Burapol Singhana
Doctor of Philosophy at Chulabhorn International College of Medicine, Thammasat University
anti-inflammatory, antibody, bioavailability, biodegradation, cannabidiol, cannabinoid, cannabis, chemical reaction, decomposition, dose (biochemistry), drug, excretion, first pass effect, hash oil, magnetic resonance imaging, medical imaging, nanoparticle, pharmacokinetics, phytochemical, polymer, protein, recycling, synergy, tetrahydrocannabinol, truck
1 2 3 4 5 6 7 8 9 10 11 12 13
31-60 of 372